Complexa Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Complexa General Information

Description

Operator of a biopharmaceutical company intended for the treatment of inflammatory and metabolic diseases. The company leverages technology to focus on the research and development of selective and reversible endogenous human cell signaling technologies targeting orphan diseases, thereby enabling healthcare professionals to better treat life-threatening diseases.

Contact Information

Website
www.complexarx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1055 Westlakes Drive
  • Suite 200
  • Berwyn, PA 19312
  • United States
+1 (412)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 1055 Westlakes Drive
  • Suite 200
  • Berwyn, PA 19312
  • United States
+1 (412)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Complexa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 09-Jun-2022 Completed Out of Business
6. Secondary Transaction - Private 01-Jan-2020 Completed Generating Revenue
5. Later Stage VC (Series C1) 16-Dec-2019 Completed Generating Revenue
4. Later Stage VC (Series C) 26-Jul-2017 Completed Generating Revenue
3. Later Stage VC (Series B) 04-Jun-2014 Completed Generating Revenue
2. Early Stage VC (Series A) 15-Jun-2012 $3.62M $3.62M Completed Startup
1. University Spin-Out 01-Jan-2008 Completed Startup
To view Complexa’s complete valuation and funding history, request access »

Complexa Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C-1
Series C
Series B 5,002,192 $0.000100 $0.27 $3.32 $3.32 1x $3.32 9.18%
Series A 1,951,922 $0.000100 $0.15 $1.82 $1.82 1x $1.82 3.58%
To view Complexa’s complete cap table history, request access »

Complexa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended for the treatment of inflammatory and metabolic diseases. The company l
Biotechnology
Berwyn, PA
6 As of 2021

Durham, NC
 

Newton, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Complexa Competitors (48)

One of Complexa’s 48 competitors is PIPr Therapeutics, a Venture Capital-Backed company based in Durham, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PIPr Therapeutics Venture Capital-Backed Durham, NC
Adiso Therapeutics Venture Capital-Backed Newton, MA
Idorsia Pharmaceuticals Corporation Allschwil, Switzerland
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Annexon Biosciences Formerly VC-backed Brisbane, CA
You’re viewing 5 of 48 competitors. Get the full list »

Complexa Patents

  • 66

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Complexa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016331314-A1 Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids Inactive 02-Oct-2015
AU-2021205027-A1 Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids Inactive 02-Oct-2015
CA-3000842-A1 Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids Inactive 02-Oct-2015
EP-3355879-A1 Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids Inactive 02-Oct-2015
EP-3355879-A4 Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids Inactive 02-Oct-2015 A61K31/201
To view Complexa’s complete patent history, request access »

Complexa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Complexa FAQs

  • When was Complexa founded?

    Complexa was founded in 2008.

  • Where is Complexa headquartered?

    Complexa is headquartered in Berwyn, PA.

  • What is the size of Complexa?

    Complexa has 6 total employees.

  • What industry is Complexa in?

    Complexa’s primary industry is Biotechnology.

  • Is Complexa a private or public company?

    Complexa is a Private company.

  • What is Complexa’s current revenue?

    The current revenue for Complexa is .

  • How much funding has Complexa raised over time?

    Complexa has raised $92.4M.

  • Who are Complexa’s competitors?

    PIPr Therapeutics, Adiso Therapeutics, Idorsia Pharmaceuticals, CytomX Therapeutics, and Annexon Biosciences are some of the 48 competitors of Complexa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process